Literature DB >> 17166924

Ascl1 defines sequentially generated lineage-restricted neuronal and oligodendrocyte precursor cells in the spinal cord.

James Battiste1, Amy W Helms, Euiseok J Kim, Trisha K Savage, Diane C Lagace, Chitra D Mandyam, Amelia J Eisch, Goichi Miyoshi, Jane E Johnson.   

Abstract

The neural basic helix-loop-helix transcription factor Ascl1 (previously Mash1) is present in ventricular zone cells in restricted domains throughout the developing nervous system. This study uses genetic fate mapping to define the stage and neural lineages in the developing spinal cord that are derived from Ascl1-expressing cells. We find that Ascl1 is present in progenitors to both neurons and oligodendrocytes, but not astrocytes. Temporal control of the fate-mapping paradigm reveals rapid cell-cycle exit and differentiation of Ascl1-expressing cells. At embryonic day 11, Ascl1 identifies neuronal-restricted precursor cells that become dorsal horn neurons in the superficial laminae. By contrast, at embryonic day 16, Ascl1 identifies oligodendrocyte-restricted precursor cells that distribute throughout the spinal cord. These data demonstrate that sequentially generated Ascl1-expressing progenitors give rise first to dorsal horn interneurons and subsequently to late-born oligodendrocytes. Furthermore, Ascl1-null cells in the spinal cord have a diminished capacity to undergo neuronal differentiation, with a subset of these cells retaining characteristics of immature glial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17166924     DOI: 10.1242/dev.02727

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  74 in total

Review 1.  Developmental genetics of vertebrate glial-cell specification.

Authors:  David H Rowitch; Arnold R Kriegstein
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

2.  Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing.

Authors:  B Zimmer; P B Kuegler; B Baudis; A Genewsky; V Tanavde; W Koh; B Tan; T Waldmann; S Kadereit; M Leist
Journal:  Cell Death Differ       Date:  2010-09-24       Impact factor: 15.828

3.  Dlx1 and Dlx2 control neuronal versus oligodendroglial cell fate acquisition in the developing forebrain.

Authors:  Magdalena A Petryniak; Gregory B Potter; David H Rowitch; John L R Rubenstein
Journal:  Neuron       Date:  2007-08-02       Impact factor: 17.173

Review 4.  Epigenetic mechanisms facilitating oligodendrocyte development, maturation, and aging.

Authors:  Sjef Copray; Jimmy Long Huynh; Falak Sher; Patrizia Casaccia-Bonnefil; Erik Boddeke
Journal:  Glia       Date:  2009-11-15       Impact factor: 7.452

Review 5.  A matter of identity: transcriptional control in oligodendrocytes.

Authors:  Michael Wegner
Journal:  J Mol Neurosci       Date:  2007-09-18       Impact factor: 3.444

6.  Asymmetric activation of Dll4-Notch signaling by Foxn4 and proneural factors activates BMP/TGFβ signaling to specify V2b interneurons in the spinal cord.

Authors:  Kamana Misra; Huijun Luo; Shengguo Li; Michael Matise; Mengqing Xiang
Journal:  Development       Date:  2013-11-20       Impact factor: 6.868

Review 7.  Transcription factors and neural stem cell self-renewal, growth and differentiation.

Authors:  Sohail Ahmed; Hui Theng Gan; Chen Sok Lam; Anuradha Poonepalli; Srinivas Ramasamy; Yvonne Tay; Muly Tham; Yuan Hong Yu
Journal:  Cell Adh Migr       Date:  2009-10-27       Impact factor: 3.405

8.  Directed differentiation of hippocampal stem/progenitor cells in the adult brain.

Authors:  Sebastian Jessberger; Nicolas Toni; Gregory D Clemenson; Jasodhara Ray; Fred H Gage
Journal:  Nat Neurosci       Date:  2008-06-29       Impact factor: 24.884

Review 9.  Radial glia in the ventral telencephalon.

Authors:  Miguel Turrero García; Corey C Harwell
Journal:  FEBS Lett       Date:  2017-09-19       Impact factor: 4.124

Review 10.  Mouse models of DNA double-strand break repair and neurological disease.

Authors:  Pierre-Olivier Frappart; Peter J McKinnon
Journal:  DNA Repair (Amst)       Date:  2008-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.